Events, Conditions, Episodes Project Group meeting minutes 11-12-2018

Events, Conditions, Episodes Project Group meeting minutes 11-12-2018





Date

2018-8-06

Time: 20:00 UTC 



Attendees

@Bruce Goldberg
@Former user (Deleted)
@Jim Case
@Yongsheng Gao
@Phil Brown
@Former user (Deleted)
@Monica Harry
@Former user (Deleted)
@Penni Hernandez
@Ed Cheetham
@David Robinson
@Rob Hausam
@Robert McClure
@Former user (Deleted)
@stefan.schulz
@Former user (Deleted)
@Yongsheng Gao
@Cathy Richardson

Apologies

@Jim Case
@Former user (Deleted)
@Rob Hausam



General Comments

  • See agenda below

Item

Description

Owner

Item

Comments/Files

Item

Description

Owner

Item

Comments/Files

1

Welcome and role call

@Bruce Goldberg





2

Recap of decisions reached at Fall business meeting in Vancouver

@Bruce Goldberg

Summary of main outcomes:

  1. The co-occurrent and due to pattern for modeling disorder combinations will be retired.

    1. Allowable associations patterns are temporal relationships (after, during before, temporally related to) and causal relationships (due to, causative agent)

    2. Simple co-occurrence (see below)

  2. Stroke model approved (see below for latest iteration)

  3. Sources of truth

    1. @Bruce Goldberg and @Jeff Piersonto develop matrix for Primary and secondary sources for each top level hierarchy (or subhierarchy)

  4.  Complex skull fractures 

    1. 20 disorder concepts (see list in attache .pptx) involving skull fractures with intracranial injury, with or without loss of consciousness for a time period, and some indicate the return to pre-existing conscious level.

    2. 40 additional concepts in SNOMED which include the "return to pre-existing conscious..."

    3. Concepts in question are classification-derived phrases
      Representation of levels of consciousness has changed between ICD-9, ICD-10 and ICD-11
      Modeling of complex associations with > 2 conditions is currently out of scope for modeling
      Recommendation:
      Inactivate these concepts

  • Attendance list

Name

Affiliation

E-mail

Jeff Pierson

IMO



Jim Case

NLM/SNOMED

jca@snomed.org

Phuong Skovgaard

SNOMED

psk@snomed.org

Eza Hafeza

EHInformatics LLC

ehafeza@gmail.com

Doris McGinnes

IMO

dmcginness@e-imo.com

Rachel Tharp

Cerner

rachel.tharp@cerner.com

Josee Mignault

CIHI

jmignault@cihi.ca

Krista Lilly

SNOMED

kli@snomed.orh

Monica Harry

SNOMED

mha@snomed.org

Penni Hernandez

SNOMED

phe@snomed.org

Toni Morrison

SNOMED

tmo@snomed.org

Peter G. Williams

SNOMED

pwi@snomed.org

Patrick Granwold

Apple

pgranwold@apple.com

Maria Braithwaite

SNOMED

mbr@snomed .org

Paul Amos

SNOMED

pam@snomed.org

Rob Hausam

Hausam Consulting

rrhausam@gmail.com



3

Secondary disorders

@Bruce Goldberg, @Yongsheng Gao



There are a large number of disorder concepts that refer to "Secondary" or "Secondary to". A query was sent to the WHO ICD MSAC (Medical and scientific advisory committee):

It is unclear from the [ICD-11] definitions associated with the various conditions that use the term "secondary" as to whether it refers to simple co-occurrence or some level of causality, or both, as most of the definitions define secondary disorders as "disorder secondary to X" which is not very helpful.
This is important from the SNOMED point of view as we are trying to separate out causality from simple temporal relationships. If by "secondary"; ICD actually means a "Complication X due to disease Y", then we would reconsider many of the terms we have that currently make a distinction between ""Complication" and "Secondary".
There is also a question concerning the phrase ‘associated with’. As it is ambiguous, it is desirable that this phrase be deprecated.

Implications on modeling and terming of existing content as part of the QI project need to be discussed and recommendations provided to the content team.



Discussion around varying uses of "secondary". Agreement that given the ambiguity of the word and its use in SNOMED, when the intent is to represent a causal sequence an FSN such as that suggested in the attached slide deck should be used. A parent of complication should be used in the definition of subtypes of "Secondary" X

Group agreed that use of GCIs to model "Secondary" X was appropriate

Question arose from @Former user (Deleted) as to whether Secondary X is a useful grouper. Example: The children of secondary diabetes can all be considered to be subtypes of diabetes. @Phil Brown mentioned the use of use of a similar organizing node (Other specific types) in the ADA classification of diabetes mellitus
Further discussion needed

4

Modeling of cerebrovascular accident

@Bruce Goldberg

@Phil Brown

  • Revised model approved during Vancouver meeting

    • Needs more testing

@stefan.schulz pointed out that GCIs may not be required for cerebrovascular accident as this can be fully defined as an acute non-traumatic brain injury with neurological dysfunction and subtypes defined with an appropriate due to relationship. This needs further discussion as acute non-traumatic brain injuries with neurological dysfunction may not fully define the meaning of a cerebrovascular accident e.g. brain metastases, infections or toxins. Stroke seems to imply a primary vascular cause.

@Bruce Goldberg to do more testing

5

Modeling of injuries

@Bruce Goldberg



  • Proposed model for modeling traumatic and non-traumatic injuries

Group agreed in principle to modeling injuries with an associated morphology of damage (for unspecified injuries) and with a role group consisting of damage and a pathological process of traumatic or non-traumatic for traumatic and non-traumatic injuries respectively

Further research into the meaning of "damage" needs to be undertaken with regard to the correct population of the damage (morphologic abnormality) hierarchy



6

Allergy topics

@Bruce Goldberg

  • Hypersensitivity/Allergy/Intolerance (to substance?)

  • Allergic contact hypersensitivity

    • Should include after exposure to X event as well as causative agent for situations in which X is other than a substance an the allergen substance has been elucidated?

      • Complication +/- sequela?

Tabled for next call

7

AOB, adjourn

ALL



Next call December 10 at 20:00 UTC






Previous Meetings

TitleCreatorModified
No content found.





Copyright © 2025, SNOMED International